There are ongoing clinical trials to treat acquired immune deficiency syndrome using the ZFN genome editing technique targeting the C-C chemokine receptor type 5 gene (CCR5 gene) of CD4+T cells (T helper cells). Here, CCR5 is linked to AIDS.